Severity: Warning
Message: Undefined array key 1
Filename: helpers/my_audit_helper.php
Line Number: 6993
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 6993
Function: _error_handler
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3911
Function: getTopKeywords
File: /var/www/html/application/controllers/Detail.php
Line: 38
Function: pubMedSearch_Global
File: /var/www/html/index.php
Line: 316
Function: require_once
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/a-2252-3164 | DOI Listing |
Ann Phys Rehabil Med
March 2025
Service de Médecine Physique et de Réadaptation, Clermont-Ferrand, INRAE, Université Clermont Auvergne, France.
Lung Cancer
March 2025
Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Background: Immune checkpoint inhibitors (ICIs) are currently included in the standard of care of the first-line treatment of advanced/metastatic non-small cell lung cancer (NSCLC). However, a relevant group of clinically unfit patients, including poor Performance Status, Elderly, and those with relevant comorbidities, are not represented in most pivotal clinical trials.
Methods: An expert panel meeting commentary was virtually held to point out the key issues in treating such 'invisible' patients and to review the available evidence.
Acad Med
March 2025
D.L. Gumucio is professor emerita, Department of Cell and Developmental Biology and Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
World J Urol
March 2025
Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!